» Articles » PMID: 23388517

Continuous Administration of Enteral Lipid- and Protein-rich Nutrition Limits Inflammation in a Human Endotoxemia Model

Overview
Journal Crit Care Med
Date 2013 Feb 8
PMID 23388517
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: An overzealous inflammatory response is an important cause of morbidity and mortality in surgical, trauma, and critically ill patients. Enteral administration of lipid-rich nutrition was previously shown to attenuate inflammation and reduce organ damage via a cholecystokinin-1 receptor-mediated vagovagal reflex in animal studies. The current preclinical study investigates the immunomodulatory potential of a custom-made enteral nutrition during systemic inflammation in man.

Design: Double-blind, randomized controlled trial.

Setting: Intensive care research unit.

Subjects: Male volunteers.

Interventions: After an overnight fast, 18 healthy male subjects received an IV bolus of Escherichia coli lipopolysaccharide (2 ng/kg). Subjects in the fasted group (n = 6) were deprived of food throughout the study, while subjects in the intervention groups were fed either custom-made lipid- and protein-rich nutrition (n = 6) or isocaloric control nutrition (n = 6) via nasojejunal tube, starting 1 hour prior to lipopolysaccharide administration until 6 hours afterward.

Measurements And Main Results: Bolus lipopolysaccharide administration resulted in a marked inflammatory response. Continuous postpyloric administration of nutrition significantly increased plasma cholecystokinin levels throughout the lipopolysaccharide-induced inflammatory response. Lipid- and protein-rich nutrition attenuated circulating levels of the proinflammatory cytokines tumor necrosis factor-α and interleukin-6 and the interleukin-1 receptor antagonist compared with control nutrition (all p < 0.05) and fasted subjects (all p < 0.05). In additional, lipid- and protein-rich nutrition augmented the anti-inflammatory response, reflected by increased plasma levels of interleukin-10 compared with fasted subjects (p < 0.0001).

Conclusions: The current preclinical study expands the immunomodulating effects of enteral nutrition as previously observed in rodents to man. Continuous administration of enteral nutrition resulted in a rapid anti-inflammatory effect. Furthermore, enrichment of the nutritional composition with lipid and protein was shown to enhance the anti-inflammatory potential. Therefore, continuous enteral administration of lipid- and protein-rich nutrition is a promising intervention to modulate the immune response in the early course of systemic inflammation in man.

Citing Articles

High-Molecular-Weight Hyaluronic Acid Can Be Used as a Food Additive to Improve the Symptoms of Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS).

Jiang Y, Jiang Y, Li L, Liu X, Hou X, Wang W Biology (Basel). 2024; 13(5).

PMID: 38785801 PMC: 11118101. DOI: 10.3390/biology13050319.


Clinical treatment for persistent inflammation, immunosuppression and catabolism syndrome in patients with severe acute pancreatitis (Review).

Zhang B, Xiao Q, Ma Q, Han L Exp Ther Med. 2023; 26(4):495.

PMID: 37753297 PMC: 10519614. DOI: 10.3892/etm.2023.12194.


Biodegradable Polymeric Nanoparticles Loaded with Flavonoids: A Promising Therapy for Inflammatory Bowel Disease.

Li M, Liu Y, Weigmann B Int J Mol Sci. 2023; 24(5).

PMID: 36901885 PMC: 10003013. DOI: 10.3390/ijms24054454.


Targeting neuroinflammation as a preventive and therapeutic approach for perioperative neurocognitive disorders.

Cheng C, Wan H, Cong P, Huang X, Wu T, He M J Neuroinflammation. 2022; 19(1):297.

PMID: 36503642 PMC: 9743533. DOI: 10.1186/s12974-022-02656-y.


Trans-auricular vagus nerve stimulation to reduce perioperative pain and morbidity: protocol for a single-blind analyser-masked randomised controlled trial.

Patel A, Bibawy P, Majeed Z, Gan W, Ackland G BJA Open. 2022; 2:None.

PMID: 35832337 PMC: 9258962. DOI: 10.1016/j.bjao.2022.100017.